Loading...

Rising Global Chronic Illness Will Drive Self-Administered Endocrine Therapies Expansion

Published
27 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
99.7%
7D
4.2%

Author's Valuation

US$1136.3% undervalued intrinsic discount

AnalystHighTarget Fair Value